WMB
60
2
JNJ
35
5
BLK
50
3
AMAT
41
6
DIS
68
-2
AON
28
2
WFC
60
2
CPB
22
-2
PRU
45
6
CB
48
2
HP
34
-10
PFG
30
3
KSS
38
2
ACN
50
-6
CSCO
66
3
FLR
50
11
MSFT
53
-2
FRT
36
2
GOOG
79
2
EBAY
39
-3
WMB
60
2
JNJ
35
5
BLK
50
3
AMAT
41
6
DIS
68
-2
AON
28
2
WFC
60
2
CPB
22
-2
PRU
45
6
CB
48
2
HP
34
-10
PFG
30
3
KSS
38
2
ACN
50
-6
CSCO
66
3
FLR
50
11
MSFT
53
-2
FRT
36
2
GOOG
79
2
EBAY
39
-3
Financhill
Back

CyberArk Software Vs. Novo Nordisk AS Industry Stock Comparison

Buy
56

CYBR
CyberArk Software

Last Price:
$320.74
Seasonality Move:
11.42%
Sell
26

NVO
Novo Nordisk AS

Last Price:
$87.33
Seasonality Move:
6.58%
Buy
56
CyberArk Software (CYBR) is a Buy

Is CyberArk Software a Buy, Sell or Hold?

  • The current CyberArk Software [CYBR] share price is $318.55. The Score for CYBR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • CYBR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYBR Stock Price Chart

What is CyberArk Software's stock price today?

  • The CyberArk Software share price today is $318.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYBR is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $88.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

CYBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.64 Buy
Relative Strength Index (14 RSI): 52.91 Buy
Chaikin Money Flow: 241563 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (313.38 - 325.8) Sell
Bollinger Bands (100): (269.01 - 310.99) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.52 Sell
Relative Strength Index (14 RSI): 27.28 Sell
Chaikin Money Flow: 14079249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.16 - 111.42) Sell
Bollinger Bands (100): (106.53 - 131.27) Sell

CYBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 316.23 Buy
20-day SMA: 320.16 Sell
50-day SMA: 305.62 Buy
200-day SMA: 271.36 Buy
8-day EMA: 316.98 Buy
20-day EMA: 316.23 Buy
50-day EMA: 306.89 Buy
200-day EMA: 272.29 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.84 Sell
20-day SMA: 105.84 Sell
50-day SMA: 108.65 Sell
200-day SMA: 126.03 Sell
8-day EMA: 99.1 Sell
20-day EMA: 103.93 Sell
50-day EMA: 109.19 Sell
200-day EMA: 117.8 Sell

CyberArk Software Earnings Growth & CYBR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.17 per share, and an increase next year of $0.66 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

CyberArk Software Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):